Nu-Life USA is a U.S. based company with headquarters in Indianapolis, Indiana and is the exclusive provider of Nu-V3, the miniaturized, wearable, non-invasive, non-pharmaceutical device and treatment program for those suffering from acute and chronic pain, anxiety, depression and sleeplessness throughout the United States and United States Territories.  Nu-Life USA holds the exclusive sales and distribution rights as well as the United States patent license for Nu-V3.

Screen Shot 2020-06-14 at 9.34.35 PM.png
Opportunity and Responsibility

Pain, anxiety, depression and sleeplessness know no boundaries. The empowered or the underserved. The wealthy or the needy. The young and the aged.  Nu-Life USA is committed to treating people in need from all walks of life.

On ear2.jpg
Three Distinct Treatment Program Models

The Nu-Life USA team has developed three treatment program models and a comprehensive telemedicine and tele-health platform to help ensure any patient who needs Nu-V3 will have access. 

Image 1.jpg
From Pre-Market to Full Market Entry

As the Nu-Life USA team prepares for market entry and operations upon regulatory clearance, they are fine tuning these treatment program models to ensure a smooth transition from our pre-market programs to full market entry. 

Screen Shot 2020-04-24 at 9.05.37 AM.png
The H.O.P.E. Initiative - Helping Our Protectors Endure

Nu-Life USA is preparing for market entry by launching The H.O.P.E. Initiative, treating healthcare workers, first responders and veterans under our IRB approved clinical programs.

SM Icon LI.png
HOPE GFM Icon.png
SM Icon FB.png